期刊文献+

埃索美拉唑抑制胃癌AGS细胞增殖与蛋白激酶B、表皮生长因子受体表达的关系 被引量:4

Relationship between the proliferation inhibition of AGS cells treated with esomeprazole and the expression of protein kinase B and epidermal growth factor receptor
原文传递
导出
摘要 目的探讨埃索美拉唑对人胃癌AGS细胞增殖、迁移、凋亡的影响及其与蛋白激酶B(Akt)、表皮生长因子受体(EGFR)表达的关系。方法分别用噻唑蓝(MTT)法和Transwell实验分析不同浓度的埃索美拉唑(0、2.5、5.0、10.0、20.0、40.0、80.0 mg/L)对胃癌AGS细胞增殖、迁移、侵袭的影响;用流式细胞术检测埃索美拉唑(40 mg/L)作用胃癌AGS细胞48 h后其细胞凋亡;分别用反转录-聚合酶链反应(RT-PCR)和Western blot方法检测埃索美拉唑(40 mg/L)作用胃癌AGS细胞48 h后Akt、EGFR、半胱氨酰天冬氨酸特异性蛋白酶(Caspase)-3、Caspase-7 mRNA和蛋白的表达。结果随着埃索美拉唑浓度的增加,胃癌AGS细胞抑制率逐渐增加(0.00、9.76%、9.97%、13.13%、24.54%、43.62%、55.59%,P=0.001),迁移细胞数逐渐减少[(247.38±7.31)、(240.35±4.30)、(225.89±7.36)、(210.27±4.16)、(181.38±6.23)、(142.46±4.13)、(122.48±6.25)个/视野,P=0.001],侵袭细胞数逐渐减少[(207.32±13.23)、(201.34±9.43)、(197.49±5.98)、(189.74±11.65)、(172.18±7.38)、(150.49±6.39)、(111.23±6.36)个/视野,P=0.001]。埃索美拉唑40 mg/L处理48 h后,细胞凋亡比例显著增加(30.50%比2.88%),Akt、Caspase-3、Caspase-7 mRNA和蛋白表达下降,EGFR mRNA和蛋白表达升高。结论埃索美拉唑能抑制胃癌AGS细胞增殖,诱导其凋亡,可能与Akt表达下降、EGFR的激活有关。 Objective To investigate the effect of esomeprazole on proliferation, migration, apoptosis of gastric cancer cell line AGS cells and its relationship with protein kinase B (Akt), epidermal growth factor receptor (EGFR) expression.Methods Methyl thiazol tetrazolium (MTT) method and Transwell model analysis were used to detect proliferation, migration and invasion ability of AGS cells treated with different concentrations of esomeprazole (0, 2.5, 5.0, 10.0, 20.0, 40.0, 80.0 mg/L). Flow cytometry was used to examine apoptosis of AGS cells treated with esomeprazole (40 mg/L) after 48 h. Reverse transcriptase-polymerase chain reaction (RT-PCR) and Western blotting were used to detect the Akt, EGFR, cysteinyl aspartate-specific protease (Caspase)-3, Caspase-7 mRNA and protein expression in AGS cells treated with esomeprazole (40 mg/L) after 48 h.Results Inhibition rate of AGS cells was increased (0.00, 9.76%, 9.97%, 13.13%, 24.54%, 43.62%, 55.59%, P=0.001) with the increase of esomeprazole concentration, while the number of migrating cells gradually declined [(247.38±7.31), (240.35±4.30), (225.89±7.36), (210.27±4.16), (181.38±6.23), (142.46±4.13), (122.48±6.25) cells per microscopic vision, P=0.001] and also that of invading cells [(207.32±13.23), (201.34±9.43), (197.49±5.98), (189.74±11.65), (172.18±7.38), (150.49±6.39), (111.23±6.36) cells per microscopic vision, P=0.001]. The apoptosis rate of AGS cells was increased significantly (30.50% vs. 2.88%) after treatment with esomeprazole (40 mg/L) for 48 h, Akt, Caspase-3 and Caspase-7 mRNA and protein expression decreased, but EGFR mRNA and protein expression increased.Conclusion Esomeprazole could inhibit AGS cells proliferation and induce the apoptosis, with a possible mechanism of Akt downregulation and EGFR activation.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2018年第2期257-260,共4页 Chinese Journal of Experimental Surgery
基金 河南省医学科技攻关省部共建项目(201701015) 河南省科技发展计划(172102310076) 河南省医学科技攻关普通项目(201403123) 郑州市科技发展计划(141PPTGG451)
关键词 埃索美拉唑 胃癌 细胞增殖 蛋白激酶B 表皮生长因子受体 Esomeprazole Gastric cancer Cell proliferation Protein kinase B Epidermal growth factor receptor
  • 相关文献

参考文献2

二级参考文献21

  • 1Cunningham D, Allum WH, Stenning SP; MAGIC Trial Participants. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer [J]. N Engl J Med, 2006, 355 (1) : 11-20.
  • 2Liang XJ, Aszalos A. Multidrug transporters as drug targets [J]. CUIT Drug Targets, 2006, 7 (8) : 911-921.
  • 3Aller SG, Yu J, Ward A, et al. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding [J]. Science, 2009, 323 (5922) : 1718-1722.
  • 4Fais S. Proton pump inhibitor-induced tumour cell death by inhibition of a detoxification mechanism [J]. J Intern Med, 2010,267 (5) : 515-525.
  • 5Fais S, De Milito A, You H, et al. Targeting vacuolar H + - A TPases as a new strategy against cancer [J]. Cancer Res, 2007,67 (22): 10627-10630.
  • 6Huber V, De Milito A, Harguindey S, et al. Proton dynamics in cancer [J]. J Transl Med, 2010, 8: 57.
  • 7Luciani F, Spada M, De Milito A, et al. Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs [J]. J N atl Cancer Inst, 2004, 96 (22): 1702-1713.
  • 8Chen M, Zou X, Luo H, et al. Effects and mechanisms of proton pump inhibitors as a novel chemosensitizer on human gastric adenocarcinoma (SGC790 1) cells [J]. Cell BioI Int, 2009, 33 (9) : 1008-1019.
  • 9Rafiee P, Theriot ME, Nelson VM, et a1. H uman esophageal microvascular endothelial cells respond to acidic pH stress by P13K1 AKT and p38 MAPK-regulated induction of Hsp70 and Hsp27 [J]. Am J Physiol Cell Physiol, 2006, 291 (5): C931-C945.
  • 10Emerling BM, Akcakanat A. Targeting PI3K1mTOR signaling in cancerj L]. Cancer Res, 2011, 71 (24): 7351-7359.

共引文献8

同被引文献20

引证文献4

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部